XM n’offre pas ses services aux résidents des États-Unis d’Amérique.

What to Watch in the Day Ahead - Thursday, May 9



<html xmlns="http://www.w3.org/1999/xhtml"><head><title>What to Watch in the Day Ahead - Thursday, May 9</title></head><body>

The Day Ahead is an email and PDF publication that includes the day's major stories and events, analyses and other features. To receive The Day Ahead, Eikon users can register at DAY/US. Thomson One users can register at RT/DAY/US. All times in ET/GMT

Warner Bros Discovery is expected to report a fall in first-quarter revenue weighed down by a weak advertising market.

The U.S. Labor Department’s weekly jobless claims data will likely show that initial claims for state unemployment benefits rose by 7,000 to a seasonally adjusted 215,000 for the week ended May 4. Meanwhile, continued jobless claims likely rose to 1.785 million for the week ended April 27, from 1.774 million in the week before.

George Mason University is scheduled to air a pre-recorded fireside chat with Federal Reserve Bank of San Francisco President Mary Daly at GMU's Marcatus Center in Fairfax, Virginia. (1400/1800)

Tapestry is expected to post a drop in third-quarter revenue as weaker demand in North America and Europe is likely to drag its business. Investors will be looking for comments on its deal with Capri, demand outlook, and the state of accessible luxury spending.

Video gaming platform Roblox is expected to report a rise in first-quarter bookings, benefiting from higher in-game spending.


Akamai Technologies is expected to report higher first-quarter revenue, likely helped by resilient demand for cloud security services.


Tower Semiconductors to report first-quarter results below analysts estimates as the company had flagged earlier that the supply glut in the automotive sector might weigh on the company's results.

EPAM is scheduled to report first-quarter revenue in line with estimates and forecast muted second-quarter revenue as inflation and high interest rates force tech clients to cut back spending.

Viatris is expected to report its first-quarter earnings. Investors are likely to look out for any changes to the company's profit forecast and the performance of its branded and generic drugs.

Charles River Laboratories is set to report its first-quarter results before markets open. The focus for the quarter will be on updates to its annual forecast and comments on spending by its clients.

3M-spinoff Solventum is expected to report first-quarter earnings before markets open. Investors will focus on the healthcare firm's outlook for the year and its growth strategy as a standalone company.


Mettler-Toledo is set to report first-quarter results after markets close. Investors will monitor any updates to the company's full-year sales and earnings per share outlook amid previously disclosed shipping delays impacting its business.

Sun Life Financial is set to report its first-quarter earnings. The second-biggest Canadian life insurer is expected to post a jump in profit.

On the Latin American front, Mexico's central bank is expected to hold its benchmark interest rate at 11%, as persistent inflation remains above the bank's target range. Separately, Mexico's national statistics agency, INEGI, is scheduled to report headline inflation likely rose 0.19% in April after gaining 0.29% the month before. On a yearly basis, inflation probably climbed 4.63% in April, after rising 4.42% in March. The core inflation is expected to gain 0.24% in April, after reporting a rise of 0.44% in the prior month. On an annual basis, core inflation in April is expected to climb 4.40%. Meanwhile, Peru's central bank is expected to lower its benchmark interest rate by 25 basis points to 5.75%. In addition, the country is scheduled to report its trade balance figures for March.




Compiled by Anjana Jayakrishnan Nair in Bengaluru; Editing by Ravi Prakash Kumar

</body></html>

Avertissement : Les entités de XM Group proposent à notre plateforme de trading en ligne un service d'exécution uniquement, autorisant une personne à consulter et/ou à utiliser le contenu disponible sur ou via le site internet, qui n'a pas pour but de modifier ou d'élargir cette situation. De tels accès et utilisation sont toujours soumis aux : (i) Conditions générales ; (ii) Avertissements sur les risques et (iii) Avertissement complet. Un tel contenu n'est par conséquent fourni que pour information générale. En particulier, sachez que les contenus de notre plateforme de trading en ligne ne sont ni une sollicitation ni une offre de participation à toute transaction sur les marchés financiers. Le trading sur les marchés financiers implique un niveau significatif de risques pour votre capital.

Tout le matériel publié dans notre Centre de trading en ligne est destiné à des fins de formation / d'information uniquement et ne contient pas – et ne doit pas être considéré comme contenant – des conseils et recommandations en matière de finance, de fiscalité des investissements ou de trading, ou un enregistrement de nos prix de trading ou une offre, une sollicitation, une transaction à propos de tout instrument financier ou bien des promotions financières non sollicitées à votre égard.

Tout contenu tiers, de même que le contenu préparé par XM, tels que les opinions, actualités, études, analyses, prix, autres informations ou liens vers des sites tiers contenus sur ce site internet sont fournis "tels quels", comme commentaires généraux sur le marché et ne constituent pas des conseils en investissement. Dans la mesure où tout contenu est considéré comme de la recherche en investissement, vous devez noter et accepter que le contenu n'a pas été conçu ni préparé conformément aux exigences légales visant à promouvoir l'indépendance de la recherche en investissement et, en tant que tel, il serait considéré comme une communication marketing selon les lois et réglementations applicables. Veuillez vous assurer que vous avez lu et compris notre Avis sur la recherche en investissement non indépendante et notre avertissement sur les risques concernant les informations susdites, qui peuvent consultés ici.

Avertissement sur les risques : votre capital est à risque. Les produits à effet de levier ne sont pas recommandés pour tous. Veuillez consulter notre Divulgation des risques